僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Bexmarilimab （FP-1305） is a potent humanized anti-CLEVER-1 IgG4-antibody with an IC50 value of 4.51 nM. Bexmarilimab is capable of inducing a phenotypic M2 to M1 immune switch of tumor-associated macrophages. Bexmarilimab can be used in research of cancer